HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chinyu Su Selected Research

Chinyu Su Research Topics

Disease

41Ulcerative Colitis
07/2022 - 10/2002
7Herpes Zoster
06/2022 - 01/2017
6Infections
06/2022 - 01/2017
6Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2021 - 10/2002
6Rheumatoid Arthritis
01/2021 - 01/2018
5Skin Neoplasms (Skin Cancer)
01/2022 - 01/2017
5Crohn Disease (Crohn's Disease)
01/2019 - 10/2002
4Necrosis
12/2021 - 01/2005
4Neoplasms (Cancer)
01/2021 - 01/2019
4Psoriatic Arthritis
01/2021 - 01/2018
3Psoriasis (Pustulosis Palmaris et Plantaris)
01/2021 - 11/2018
2Pulmonary Embolism
01/2021 - 11/2019
2Venous Thrombosis (Deep-Vein Thrombosis)
01/2021 - 11/2019
2Inflammation (Inflammations)
01/2021 - 01/2020
2Opportunistic Infections (Opportunistic Infection)
01/2021 - 01/2019
2Opioid-Induced Constipation
11/2011 - 11/2009
1Clostridium Infections
07/2022
1Atherosclerosis
01/2021
1Body Weight (Weight, Body)
01/2021
1Hyperlipidemias (Hyperlipidemia)
01/2021
1Venous Thromboembolism
11/2019
1Melanoma (Melanoma, Malignant)
01/2019
1Hemorrhage
01/2019
1Fetal Death
11/2018
1Muscle Cramp (Cramp)
11/2011
1Abdominal Pain (Pain, Abdominal)
11/2011
1Constipation
11/2009
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
11/2009
1Pain (Aches)
11/2009
1Metabolic Bone Diseases (Osteopenia)
04/2006
1Osteoporosis
04/2006

Drug/Important Bio-Agent (IBA)

37tofacitinibIBA
07/2022 - 08/2012
28Janus Kinase InhibitorsIBA
07/2022 - 08/2012
5Tumor Necrosis Factor InhibitorsIBA
06/2022 - 01/2017
4Infliximab (Remicade)FDA Link
01/2017 - 10/2002
3LipidsIBA
01/2021 - 01/2017
2C-Reactive ProteinIBA
04/2022 - 12/2021
2Pharmaceutical PreparationsIBA
01/2022 - 09/2019
2Creatine Kinase (Creatine Phosphokinase)IBA
09/2021 - 01/2021
2Biological ProductsIBA
01/2021 - 01/2019
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2019 - 04/2006
2methylnaltrexoneFDA Link
11/2011 - 11/2009
2CytokinesIBA
04/2006 - 10/2002
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2006 - 10/2002
1Delayed-Action PreparationsIBA
01/2022
1P-2 (P 2)IBA
06/2021
1omega-Chloroacetophenone (Mace)IBA
01/2021
1lipoprotein cholesterolIBA
01/2021
1CreatinineIBA
01/2021
1AlbuminsIBA
01/2021
1CholesterolIBA
01/2021
1Immunosuppressive Agents (Immunosuppressants)IBA
09/2019
1Janus KinasesIBA
01/2018
1Adalimumab (Humira)FDA Link
01/2017
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
01/2016
1mu Opioid Receptors (mu Opioid Receptor)IBA
11/2009
1Opioid Analgesics (Opioids)IBA
11/2009
1LaxativesIBA
11/2009
1Diphosphonates (Bisphosphonates)IBA
04/2006
1Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric
06/2004
1Azathioprine (Imuran)FDA LinkGeneric
06/2004
1Monoclonal AntibodiesIBA
10/2002

Therapy/Procedure

14Therapeutics
04/2022 - 10/2002
1Aftercare (After-Treatment)
11/2021
1Drug Tapering
07/2021
1Analgesia
11/2009